Thermo Fisher Scientific (TMO) Market Capitalization (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Market Capitalization for 18 consecutive years, with $189.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 23.04% year-over-year to $189.7 billion; the trailing twelve-month figure through Jun 2026 stood at $189.7 billion (up 23.04% YoY), and the FY2025 full-year result was $215.3 billion, up 9.68% from the prior year.
• Market Capitalization grew to $189.7 billion in Q2 2026 per TMO's latest filing, from $175.9 billion in the prior quarter.
• Across five years, Market Capitalization topped out at $235.0 billion in Q3 2024 and bottomed at $154.2 billion in Q2 2025.
• Historically, Market Capitalization has averaged $202.3 billion across 5 years, with a median of $201.9 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization advanced 29.3% in 2022, then slipped 27.02% in 2025.
• Over 5 years, Market Capitalization stood at $212.3 billion in 2022, then retreated by 4.64% to $202.4 billion in 2023, then slipped by 3.03% to $196.3 billion in 2024, then gained by 9.68% to $215.3 billion in 2025, then declined by 11.88% to $189.7 billion in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $189.7 billion, $175.9 billion, and $215.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.